Table 3.
Variables | Number of patients | Cumulative 5-year PFS rate | p | 5-year PFS | p |
---|---|---|---|---|---|
HR (95% CI) | |||||
Age | |||||
<60 | 102 | 23.2% | 0.992 | ||
≥60 | 19 | 26.3% | |||
Gender | |||||
Male | 117 | 23.2% | 0.372 | ||
Female | 4 | 50.0% | |||
Stage | |||||
IVa | 35 | 38.7% | <0.001∗ | 1 | |
IVb | 86 | 20.0% | 2.097 (1.255–3.505) | 0.005 | |
T stage | |||||
1-2 | 28 | 26.2% | 0.735 | ||
3-4 | 93 | 23.4% | |||
N stage | |||||
Negative | 40 | 47.3% | <0.001∗ | 1 | |
Positive | 81 | 12.0% | 1.940 (1.148–3.279) | 0.013 | |
Chemotherapy | |||||
PF | 83 | 23.0% | 0.465 | ||
TPF | 38 | 26.4% | |||
Alcohol | |||||
Never | 30 | 33.1% | 0.206 | ||
Yes | 91 | 20.8% | |||
Smoking | |||||
Never | 29 | 39.8% | 0.009 ∗ | ||
Yes | 92 | 19.0% | |||
Betel nuts | |||||
Never | 31 | 22.7% | 0.337 | ||
Yes | 90 | 23.5% | |||
OPN | |||||
Negative | 27 | 61.8% | <0.001∗ | 1 | |
Positive | 94 | 13.2% | 2.509 (1.256–5.009) | 0.009 |
CI, confidence interval; HR, hazard ratio.
∗Indicates significantly difference (p < 0.05).